{"id":4980,"date":"2024-11-04T13:05:14","date_gmt":"2024-11-04T21:05:14","guid":{"rendered":"https:\/\/grail.com\/?post_type=press-release&#038;p=4980"},"modified":"2024-11-04T13:05:15","modified_gmt":"2024-11-04T21:05:15","slug":"grail-to-present-at-the-canaccord-genuity-medtech-diagnostics-and-digital-health-services-forum","status":"publish","type":"press-release","link":"https:\/\/grail.com\/press-releases\/grail-to-present-at-the-canaccord-genuity-medtech-diagnostics-and-digital-health-services-forum\/","title":{"rendered":"GRAIL to Present at the Canaccord Genuity MedTech, Diagnostics and Digital Health &amp; Services Forum"},"content":{"rendered":"\n<p class=\"base-block\"><strong>MENLO PARK, Calif., Nov. 4, 2024\u00a0<\/strong>\u2014 GRAIL, Inc. (Nasdaq: GRAL), a healthcare company whose mission is to detect cancer early when it can be cured, today announced that company management will present at the Canaccord Genuity MedTech, Diagnostics and Digital Health &amp; Services Forum in New York on Thursday, Nov. 21 at 11:00 a.m. ET.\u00a0\u00a0<\/p>\n\n\n\n<p class=\"base-block\">Live and replay webcasts may be accessed in the investor relations section of GRAIL\u2019s website at <a href=\"http:\/\/investors.grail.com\" target=\"_blank\" rel=\"noreferrer noopener\">investors.grail.com<\/a>. The webcast will be archived and available for reply for at least 30 days after the event.<\/p>\n\n\n\n<p class=\"base-block\"><strong>About GRAIL<\/strong><br>GRAIL is a healthcare company whose mission is to detect cancer early, when it can be cured. GRAIL is focused on alleviating the global burden of cancer by using the power of next-generation sequencing, population-scale clinical studies, and state-of-the-art machine learning, software, and automation to detect and identify multiple deadly cancer types in earlier stages. GRAIL\u2019s targeted methylation-based platform can support the continuum of care for screening and precision oncology, including multi-cancer early detection in symptomatic patients, risk stratification, minimal residual disease detection, biomarker subtyping, treatment and recurrence monitoring. GRAIL is headquartered in Menlo Park, CA with locations in Washington, D.C., North Carolina, and the United Kingdom.\u00a0<\/p>\n\n\n\n<p class=\"base-block\">For more information, visit <a href=\"http:\/\/www.grail.com\/\">grail.com<\/a>.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>MENLO PARK, Calif., Nov. 4, 2024\u00a0\u2014 GRAIL, Inc. (Nasdaq: GRAL), a healthcare company whose mission is to detect cancer early when it can be cured, today announced that company management will present at the Canaccord Genuity MedTech, Diagnostics and Digital Health &amp; Services Forum in New York on Thursday, Nov. 21 at 11:00 a.m. ET.\u00a0\u00a0 [&hellip;]<\/p>\n","protected":false},"featured_media":2834,"parent":0,"menu_order":0,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"class_list":["post-4980","press-release","type-press-release","status-publish","format-standard","has-post-thumbnail","hentry"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v26.2 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>GRAIL to Present at the Canaccord Genuity MedTech, Diagnostics and Digital Health &amp; Services Forum - GRAIL<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/grail.com\/press-releases\/grail-to-present-at-the-canaccord-genuity-medtech-diagnostics-and-digital-health-services-forum\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"GRAIL to Present at the Canaccord Genuity MedTech, Diagnostics and Digital Health &amp; Services Forum - GRAIL\" \/>\n<meta property=\"og:description\" content=\"MENLO PARK, Calif., Nov. 4, 2024\u00a0\u2014 GRAIL, Inc. (Nasdaq: GRAL), a healthcare company whose mission is to detect cancer early when it can be cured, today announced that company management will present at the Canaccord Genuity MedTech, Diagnostics and Digital Health &amp; Services Forum in New York on Thursday, Nov. 21 at 11:00 a.m. ET.\u00a0\u00a0 [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/grail.com\/press-releases\/grail-to-present-at-the-canaccord-genuity-medtech-diagnostics-and-digital-health-services-forum\/\" \/>\n<meta property=\"og:site_name\" content=\"GRAIL\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/grailbio\/\" \/>\n<meta property=\"article:modified_time\" content=\"2024-11-04T21:05:15+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/assets.grail.com\/wp-content\/uploads\/2022\/06\/studies-overview.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1136\" \/>\n\t<meta property=\"og:image:height\" content=\"852\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:site\" content=\"@grailbio\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/grail.com\/press-releases\/grail-to-present-at-the-canaccord-genuity-medtech-diagnostics-and-digital-health-services-forum\/\",\"url\":\"https:\/\/grail.com\/press-releases\/grail-to-present-at-the-canaccord-genuity-medtech-diagnostics-and-digital-health-services-forum\/\",\"name\":\"GRAIL to Present at the Canaccord Genuity MedTech, Diagnostics and Digital Health &amp; Services Forum - GRAIL\",\"isPartOf\":{\"@id\":\"https:\/\/grail.com\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/grail.com\/press-releases\/grail-to-present-at-the-canaccord-genuity-medtech-diagnostics-and-digital-health-services-forum\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/grail.com\/press-releases\/grail-to-present-at-the-canaccord-genuity-medtech-diagnostics-and-digital-health-services-forum\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/assets.grail.com\/wp-content\/uploads\/2022\/06\/studies-overview.jpg\",\"datePublished\":\"2024-11-04T21:05:14+00:00\",\"dateModified\":\"2024-11-04T21:05:15+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/grail.com\/press-releases\/grail-to-present-at-the-canaccord-genuity-medtech-diagnostics-and-digital-health-services-forum\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/grail.com\/press-releases\/grail-to-present-at-the-canaccord-genuity-medtech-diagnostics-and-digital-health-services-forum\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/grail.com\/press-releases\/grail-to-present-at-the-canaccord-genuity-medtech-diagnostics-and-digital-health-services-forum\/#primaryimage\",\"url\":\"https:\/\/assets.grail.com\/wp-content\/uploads\/2022\/06\/studies-overview.jpg\",\"contentUrl\":\"https:\/\/assets.grail.com\/wp-content\/uploads\/2022\/06\/studies-overview.jpg\",\"width\":1136,\"height\":852,\"caption\":\"grail cancer research scientist\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/grail.com\/press-releases\/grail-to-present-at-the-canaccord-genuity-medtech-diagnostics-and-digital-health-services-forum\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/grail.com\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"GRAIL to Present at the Canaccord Genuity MedTech, Diagnostics and Digital Health &amp; Services Forum\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/grail.com\/#website\",\"url\":\"https:\/\/grail.com\/\",\"name\":\"GRAIL\",\"description\":\"Detect cancer early, when it can be cured\",\"publisher\":{\"@id\":\"https:\/\/grail.com\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/grail.com\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/grail.com\/#organization\",\"name\":\"GRAIL, LLC\",\"url\":\"https:\/\/grail.com\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/grail.com\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/assets.grail.com\/wp-content\/uploads\/2021\/01\/cropped-favicon-G.png\",\"contentUrl\":\"https:\/\/assets.grail.com\/wp-content\/uploads\/2021\/01\/cropped-favicon-G.png\",\"width\":512,\"height\":512,\"caption\":\"GRAIL, LLC\"},\"image\":{\"@id\":\"https:\/\/grail.com\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/grailbio\/\",\"https:\/\/x.com\/grailbio\",\"https:\/\/www.linkedin.com\/company\/grail-inc.\/\"]}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"GRAIL to Present at the Canaccord Genuity MedTech, Diagnostics and Digital Health &amp; Services Forum - GRAIL","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/grail.com\/press-releases\/grail-to-present-at-the-canaccord-genuity-medtech-diagnostics-and-digital-health-services-forum\/","og_locale":"en_US","og_type":"article","og_title":"GRAIL to Present at the Canaccord Genuity MedTech, Diagnostics and Digital Health &amp; Services Forum - GRAIL","og_description":"MENLO PARK, Calif., Nov. 4, 2024\u00a0\u2014 GRAIL, Inc. (Nasdaq: GRAL), a healthcare company whose mission is to detect cancer early when it can be cured, today announced that company management will present at the Canaccord Genuity MedTech, Diagnostics and Digital Health &amp; Services Forum in New York on Thursday, Nov. 21 at 11:00 a.m. ET.\u00a0\u00a0 [&hellip;]","og_url":"https:\/\/grail.com\/press-releases\/grail-to-present-at-the-canaccord-genuity-medtech-diagnostics-and-digital-health-services-forum\/","og_site_name":"GRAIL","article_publisher":"https:\/\/www.facebook.com\/grailbio\/","article_modified_time":"2024-11-04T21:05:15+00:00","og_image":[{"width":1136,"height":852,"url":"https:\/\/assets.grail.com\/wp-content\/uploads\/2022\/06\/studies-overview.jpg","type":"image\/jpeg"}],"twitter_card":"summary_large_image","twitter_site":"@grailbio","twitter_misc":{"Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/grail.com\/press-releases\/grail-to-present-at-the-canaccord-genuity-medtech-diagnostics-and-digital-health-services-forum\/","url":"https:\/\/grail.com\/press-releases\/grail-to-present-at-the-canaccord-genuity-medtech-diagnostics-and-digital-health-services-forum\/","name":"GRAIL to Present at the Canaccord Genuity MedTech, Diagnostics and Digital Health &amp; Services Forum - GRAIL","isPartOf":{"@id":"https:\/\/grail.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/grail.com\/press-releases\/grail-to-present-at-the-canaccord-genuity-medtech-diagnostics-and-digital-health-services-forum\/#primaryimage"},"image":{"@id":"https:\/\/grail.com\/press-releases\/grail-to-present-at-the-canaccord-genuity-medtech-diagnostics-and-digital-health-services-forum\/#primaryimage"},"thumbnailUrl":"https:\/\/assets.grail.com\/wp-content\/uploads\/2022\/06\/studies-overview.jpg","datePublished":"2024-11-04T21:05:14+00:00","dateModified":"2024-11-04T21:05:15+00:00","breadcrumb":{"@id":"https:\/\/grail.com\/press-releases\/grail-to-present-at-the-canaccord-genuity-medtech-diagnostics-and-digital-health-services-forum\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/grail.com\/press-releases\/grail-to-present-at-the-canaccord-genuity-medtech-diagnostics-and-digital-health-services-forum\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/grail.com\/press-releases\/grail-to-present-at-the-canaccord-genuity-medtech-diagnostics-and-digital-health-services-forum\/#primaryimage","url":"https:\/\/assets.grail.com\/wp-content\/uploads\/2022\/06\/studies-overview.jpg","contentUrl":"https:\/\/assets.grail.com\/wp-content\/uploads\/2022\/06\/studies-overview.jpg","width":1136,"height":852,"caption":"grail cancer research scientist"},{"@type":"BreadcrumbList","@id":"https:\/\/grail.com\/press-releases\/grail-to-present-at-the-canaccord-genuity-medtech-diagnostics-and-digital-health-services-forum\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/grail.com\/"},{"@type":"ListItem","position":2,"name":"GRAIL to Present at the Canaccord Genuity MedTech, Diagnostics and Digital Health &amp; Services Forum"}]},{"@type":"WebSite","@id":"https:\/\/grail.com\/#website","url":"https:\/\/grail.com\/","name":"GRAIL","description":"Detect cancer early, when it can be cured","publisher":{"@id":"https:\/\/grail.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/grail.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/grail.com\/#organization","name":"GRAIL, LLC","url":"https:\/\/grail.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/grail.com\/#\/schema\/logo\/image\/","url":"https:\/\/assets.grail.com\/wp-content\/uploads\/2021\/01\/cropped-favicon-G.png","contentUrl":"https:\/\/assets.grail.com\/wp-content\/uploads\/2021\/01\/cropped-favicon-G.png","width":512,"height":512,"caption":"GRAIL, LLC"},"image":{"@id":"https:\/\/grail.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/grailbio\/","https:\/\/x.com\/grailbio","https:\/\/www.linkedin.com\/company\/grail-inc.\/"]}]}},"_links":{"self":[{"href":"https:\/\/grail.com\/wp-json\/wp\/v2\/press-release\/4980","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/grail.com\/wp-json\/wp\/v2\/press-release"}],"about":[{"href":"https:\/\/grail.com\/wp-json\/wp\/v2\/types\/press-release"}],"version-history":[{"count":2,"href":"https:\/\/grail.com\/wp-json\/wp\/v2\/press-release\/4980\/revisions"}],"predecessor-version":[{"id":4992,"href":"https:\/\/grail.com\/wp-json\/wp\/v2\/press-release\/4980\/revisions\/4992"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/grail.com\/wp-json\/wp\/v2\/media\/2834"}],"wp:attachment":[{"href":"https:\/\/grail.com\/wp-json\/wp\/v2\/media?parent=4980"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}